NCT03191578View on ClinicalTrials.gov

Immunological Response to Intravesical BCG Therapy of Superficial Bladder Cancer by Prior Administration of RUTI®

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 16, 2017

Primary Completion Date

January 14, 2020

Study Completion Date

December 22, 2022

Conditions
High-Risk Non-Muscle-Invasive Bladder Cancer
Interventions
DRUG

RUTI®

Administration of RUTI®

DRUG

Placebo

Administration of placebo

Trial Locations (1)

08916

Germans Trias i Pujol Hospital, Badalona

Sponsors
All Listed Sponsors
collaborator

Fundació Institut Germans Trias i Pujol

OTHER

lead

Archivel Farma S.L.

INDUSTRY